Organization
Paion AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Paion AG
... DGAP-News: PAION AG / Key word(s): Conference available for one-on-one meetings at these events. ...
... PARTNER R-PHARM IN RUSSIA DGAP-News: PAION AG / Key word(s): Research Update PAION ANNOUNCES CLINICAL DEVELOPMENT PROGRESS WITH ...
... DGAP-News: PAION AG / Key word(s): Quarterly / Interim Statement - Conference call (in ...
... DGAP-News: PAION AG / Key word(s): Conference representatives will be available for one-on-one meetings ...
... DGAP-News: PAION AG / Key word(s): Final Results - Conference call (in English) today ...
... Pharmaceuticals · Fresenius Kabi · AstraZeneca · Hameln Pharmaceuticals · Pfizer · PAION AG · AbbVie · Baxter International, Inc. · This report discusses promising ...
... DGAP-News: PAION AG / Key word(s): Change of Personnel The issuer is solely responsible ...
... REMIMAZOLAM IN THE U.S. AS SUFFICIENT; NO SECOND INTRANASAL STUDY REQUIRED DGAP-Ad-hoc: PAION AG / Key word(s): Research Update PAION AG: FDA CONSIDERS CURRENT HUMAN ...
... THE CHEST ANNUAL MEETING 2017 DGAP-News: PAION AG / Key word(s): Conference PAION AG: REMIMAZOLAM PHASE III BRONCOSCOPY DATA ...
... DGAP-News: PAION AG / Key word(s): Patent agent" was published under Patent No. JP ...
Subscribe now for full coverage on Paion AG
Start My Free Trial